Smithsonian Magazine on MSN
A New Trial Put Immune System-Boosting Therapies to the Test to Fight HIV, Raising Hopes for Keeping the Virus at Bay
In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
A new study led by researchers at Emory University's Rollins School of Public Health, published Monday by JAMA Network Open, ...
In fact, doctors should feel perfectly comfortable prescribing them to any adult or adolescent who walks into their office and asks, says Dr. Darrell Tan, a physician-scientist at St. Michael's ...
South Africans are calling on the government to swiftly roll out Lenacapavir–an HIV prevention drug–to reduce the rate of ...
Activists urge India to waive clinical trial requirements for lenacapavir, as patent barriers threaten access to the vital ...
5don MSN
Common water pill may help HIV medicines work faster and reduce inflammation, early study suggests
An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful ...
Global News on MSN
Health Matters: New HIV medication guidelines released
As Monday marks world AIDS day, a coalition of doctors have released new recommendations for prescribing medications which can help prevent HIV infection. The goal of these recommendations is to help ...
A small UCSF study has shown promising signs of a potential functional HIV cure. After receiving a mix of vaccines, ...
Scientists tested a multi-step immune-based therapy designed to retrain the body to control HIV without continuous antiviral treatment.
South Africa has begun administering lenacapavir, a long-acting HIV prevention drug, to selected individuals as part of a new study led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results